Leonteq Securities AG’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Leonteq Securities AG’s Portfolio GBT Stock Details GBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-500	Closed	-$34K	–	1391
2022 Q3	$34K	Hold	500	–	–	﹤0.01%	873
2022 Q2	$16K	Hold	500	–	–	﹤0.01%	1013
2022 Q1	$17.3K	Hold	500	–	–	﹤0.01%	1022
2021 Q4	$14.6K	Buy	+500	New	+$15.5K	﹤0.01%	1116
2021 Q3	–	Sell	-660	Closed	-$23.1K	–	1243
2021 Q2	$23.1K	Sell	660 -750	-53%	-$29.3K	﹤0.01%	929
2021 Q1	$57.5K	Sell	1,410 -2,273	-62%	-$104K	﹤0.01%	770
2020 Q4	$160K	Buy	+3,683	New	+$182K	0.01%	600

Other funds holding GBT

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Leonteq Securities AG's GBT Position: Q4 2022 in Review

Leonteq Securities AG sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 500 shares — an estimated $34K sold.

Leonteq Securities AG first reported a position in GBT in Q4 2020 and held it in 7 quarters. The position peaked at $160K in Q4 2020. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.

Leonteq Securities AG reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
Leonteq Securities AG sold 500 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $34K.
Leonteq Securities AG first reported a position in Global Blood Therapeutics, Inc. in Q4 2020 and held it in 7 quarters.
Leonteq Securities AG's Global Blood Therapeutics, Inc. position peaked at $160K in Q4 2020.
2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.

Based on Leonteq Securities AG's 13F filing for Q4 2022, filed 26 Mar 2026.